Through a discovery-replication design, our study provides compelling evidence that genetic variants in the ALDH1 family, particularly ALDH1A2 rs16939929 A>G, may serve as promising prognostic biomarkers for prostate cancer. Here, ALDH1A2 is linked to prostate carcinoma.